Related Experiment Videos
[Cytomegalovirus infections in AIDS]
1Maladies infectieuses et tropicales médecine interne, Hôtel-Dieu, Nantes.
La Revue Du Praticien
|March 15, 1995
Summary
Cytomegalovirus (CMV) infection is a common opportunistic infection in advanced AIDS patients. Early diagnosis and new treatments, including oral antivirals and prophylaxis, aim to improve outcomes for CMV disease in this population.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Context:
- Cytomegalovirus (CMV) is the most common systemic opportunistic infection in patients with Acquired Immunodeficiency Syndrome (AIDS).
- It typically occurs in individuals with profound immunodeficiency, characterized by CD4 cell counts below 50/microL.
- The most frequent manifestations involve the retina and gastrointestinal tract.
Purpose:
- To review the epidemiology, diagnosis, and current treatment strategies for Cytomegalovirus (CMV) infection in patients with AIDS.
- To highlight the challenges in managing CMV disease and discuss potential future therapeutic advancements.
Summary:
- CMV infection affects nearly 40% of AIDS patients with severe immunodeficiency (CD4 < 50/microL), primarily manifesting as retinitis and colitis.
- Diagnosis involves fundus examination for retinitis and clinical symptoms with biopsy/culture for other sites like colitis, esophagitis, hepatitis, encephalitis, and pneumonitis.
- Current treatments, ganciclovir and foscarnet, are administered intravenously for induction and lifelong maintenance therapy to prevent recurrence.
Impact:
- Improved diagnostic approaches, such as regular fundus examinations for AIDS patients, are crucial for early detection of CMV retinitis.
- The development of orally administered antivirals, combination therapies, novel potent drugs, and prophylactic strategies holds promise for enhancing the prognosis of CMV infection in AIDS.
- These advancements are essential for reducing morbidity and mortality associated with CMV disease in immunocompromised individuals.